LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
25.33
-0.49 (-1.91%)
Mar 31, 2025, 1:22 PM EDT - Market open
LENZ Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for LENZ Therapeutics stock have an average target of 38, with a low estimate of 32 and a high estimate of 47. The average target predicts an increase of 50.02% from the current stock price of 25.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $44 → $47 | Strong Buy | Maintains | $44 → $47 | +85.55% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +50.02% | Nov 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $37 | Buy | Initiates | $37 | +46.07% | Sep 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 | Buy | Maintains | $36 | +42.12% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +50.02% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
8.35M
Revenue Next Year
53.08M
from 8.35M
Increased by 535.40%
EPS This Year
-3.03
from -2.34
EPS Next Year
-2.86
from -3.03
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 12.9M | 66.4M |
| Avg | 8.4M | 53.1M |
| Low | 5.9M | 40.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | - | 694.7% |
| Avg | - | 535.4% |
| Low | - | 389.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.51 | -1.93 | 0.17 |
| Avg | -3.03 | -2.86 | -0.86 |
| Low | -4.23 | -3.81 | -1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.